nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC22A5—Dactinomycin—uterine cancer	0.214	0.718	CbGbCtD
Niacin—CYP2D6—Progesterone—uterine cancer	0.0644	0.216	CbGbCtD
Niacin—CYP2D6—Doxorubicin—uterine cancer	0.0197	0.066	CbGbCtD
Niacin—QPRT—renal system—uterine cancer	0.0146	0.0719	CbGeAlD
Niacin—QPRT—female reproductive system—uterine cancer	0.0117	0.0576	CbGeAlD
Niacin—Salicylic acid—AKR1C1—uterine cancer	0.011	1	CrCbGaD
Niacin—NNMT—myometrium—uterine cancer	0.00947	0.0465	CbGeAlD
Niacin—NNMT—uterine cervix—uterine cancer	0.00737	0.0362	CbGeAlD
Niacin—NNMT—smooth muscle tissue—uterine cancer	0.00716	0.0352	CbGeAlD
Niacin—NNMT—decidua—uterine cancer	0.00702	0.0345	CbGeAlD
Niacin—NNMT—renal system—uterine cancer	0.0069	0.0339	CbGeAlD
Niacin—NNMT—endometrium—uterine cancer	0.00667	0.0328	CbGeAlD
Niacin—SLC16A3—myometrium—uterine cancer	0.00647	0.0318	CbGeAlD
Niacin—NNMT—mammalian vulva—uterine cancer	0.00645	0.0317	CbGeAlD
Niacin—NNMT—uterus—uterine cancer	0.00614	0.0302	CbGeAlD
Niacin—HCAR2—lymph node—uterine cancer	0.00574	0.0282	CbGeAlD
Niacin—NNMT—female reproductive system—uterine cancer	0.00552	0.0271	CbGeAlD
Niacin—SLC16A3—epithelium—uterine cancer	0.00508	0.025	CbGeAlD
Niacin—SLC16A3—uterine cervix—uterine cancer	0.00503	0.0247	CbGeAlD
Niacin—NNMT—female gonad—uterine cancer	0.00503	0.0247	CbGeAlD
Niacin—NNMT—vagina—uterine cancer	0.00499	0.0245	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—uterine cancer	0.00489	0.024	CbGeAlD
Niacin—SLC16A3—decidua—uterine cancer	0.0048	0.0236	CbGeAlD
Niacin—SLC16A3—renal system—uterine cancer	0.00471	0.0231	CbGeAlD
Niacin—SLC16A3—endometrium—uterine cancer	0.00455	0.0224	CbGeAlD
Niacin—SLC16A3—uterus—uterine cancer	0.0042	0.0206	CbGeAlD
Niacin—SLC16A3—female reproductive system—uterine cancer	0.00377	0.0185	CbGeAlD
Niacin—SLC16A3—female gonad—uterine cancer	0.00343	0.0169	CbGeAlD
Niacin—NNMT—lymph node—uterine cancer	0.00323	0.0159	CbGeAlD
Niacin—SLC16A1—epithelium—uterine cancer	0.00308	0.0152	CbGeAlD
Niacin—SLC16A1—decidua—uterine cancer	0.00291	0.0143	CbGeAlD
Niacin—SLC16A1—renal system—uterine cancer	0.00286	0.0141	CbGeAlD
Niacin—SLC16A1—endometrium—uterine cancer	0.00277	0.0136	CbGeAlD
Niacin—SLC16A1—uterus—uterine cancer	0.00255	0.0125	CbGeAlD
Niacin—SLCO2B1—decidua—uterine cancer	0.00251	0.0123	CbGeAlD
Niacin—SLCO2B1—renal system—uterine cancer	0.00246	0.0121	CbGeAlD
Niacin—SLC5A8—NRF2 pathway—GPX3—uterine cancer	0.00236	0.0306	CbGpPWpGaD
Niacin—NNMT—Metapathway biotransformation—AKR1C1—uterine cancer	0.00233	0.0302	CbGpPWpGaD
Niacin—SLC16A1—female reproductive system—uterine cancer	0.00229	0.0113	CbGeAlD
Niacin—SLC22A5—myometrium—uterine cancer	0.00225	0.011	CbGeAlD
Niacin—SLC16A3—lymph node—uterine cancer	0.00221	0.0108	CbGeAlD
Niacin—SLCO2B1—uterus—uterine cancer	0.00219	0.0108	CbGeAlD
Niacin—SLC16A1—female gonad—uterine cancer	0.00209	0.0102	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—GPX3—uterine cancer	0.00204	0.0265	CbGpPWpGaD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.00197	0.0256	CbGpPWpGaD
Niacin—SLCO2B1—female reproductive system—uterine cancer	0.00197	0.00969	CbGeAlD
Niacin—NNMT—Biological oxidations—CYP11A1—uterine cancer	0.00192	0.0249	CbGpPWpGaD
Niacin—NNMT—Metapathway biotransformation—CYP11A1—uterine cancer	0.0019	0.0246	CbGpPWpGaD
Niacin—SLCO2B1—female gonad—uterine cancer	0.00179	0.00882	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—AKR1C3—uterine cancer	0.00179	0.0232	CbGpPWpGaD
Niacin—SLC22A5—uterine cervix—uterine cancer	0.00175	0.00859	CbGeAlD
Niacin—SLC22A5—renal system—uterine cancer	0.00163	0.00803	CbGeAlD
Niacin—SLC22A5—endometrium—uterine cancer	0.00158	0.00777	CbGeAlD
Niacin—NNMT—Biological oxidations—CYP19A1—uterine cancer	0.00142	0.0183	CbGpPWpGaD
Niacin—NNMT—Metapathway biotransformation—CYP19A1—uterine cancer	0.0014	0.0181	CbGpPWpGaD
Niacin—SLC16A1—lymph node—uterine cancer	0.00134	0.00659	CbGeAlD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFB11—uterine cancer	0.00133	0.0172	CbGpPWpGaD
Niacin—SLC22A5—female reproductive system—uterine cancer	0.00131	0.00643	CbGeAlD
Niacin—SLC22A5—female gonad—uterine cancer	0.00119	0.00585	CbGeAlD
Niacin—SLC22A5—vagina—uterine cancer	0.00118	0.00582	CbGeAlD
Niacin—SLC5A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00117	0.0152	CbGpPWpGaD
Niacin—SLCO2B1—lymph node—uterine cancer	0.00115	0.00567	CbGeAlD
Niacin—CYP2D6—renal system—uterine cancer	0.00105	0.00518	CbGeAlD
Niacin—CYP2D6—female reproductive system—uterine cancer	0.000845	0.00415	CbGeAlD
Niacin—QPRT—Metabolism—NDUFB11—uterine cancer	0.000818	0.0106	CbGpPWpGaD
Niacin—QPRT—Metabolism—SRD5A2—uterine cancer	0.000818	0.0106	CbGpPWpGaD
Niacin—CYP2D6—female gonad—uterine cancer	0.000769	0.00378	CbGeAlD
Niacin—SLC22A5—lymph node—uterine cancer	0.000766	0.00376	CbGeAlD
Niacin—NNMT—Metabolism—NDUFB11—uterine cancer	0.000761	0.00986	CbGpPWpGaD
Niacin—NNMT—Metabolism—SRD5A2—uterine cancer	0.000761	0.00986	CbGpPWpGaD
Niacin—QPRT—Disease—AKR1B10—uterine cancer	0.00076	0.00985	CbGpPWpGaD
Niacin—QPRT—Disease—RNF43—uterine cancer	0.00063	0.00816	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKR1B1—uterine cancer	0.000592	0.00767	CbGpPWpGaD
Niacin—QPRT—Metabolism—STAR—uterine cancer	0.000592	0.00767	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000574	0.00743	CbGpPWpGaD
Niacin—Dermatitis contact—Doxorubicin—uterine cancer	0.000558	0.00136	CcSEcCtD
Niacin—Oesophagitis—Epirubicin—uterine cancer	0.000557	0.00136	CcSEcCtD
Niacin—Eructation—Doxorubicin—uterine cancer	0.000554	0.00135	CcSEcCtD
Niacin—Rash maculo-papular—Epirubicin—uterine cancer	0.000554	0.00135	CcSEcCtD
Niacin—NNMT—Metabolism—AKR1B1—uterine cancer	0.00055	0.00713	CbGpPWpGaD
Niacin—NNMT—Metabolism—STAR—uterine cancer	0.00055	0.00713	CbGpPWpGaD
Niacin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000546	0.00133	CcSEcCtD
Niacin—Asthenia—Progesterone—uterine cancer	0.000544	0.00133	CcSEcCtD
Niacin—Hypoaesthesia—Etoposide—uterine cancer	0.000544	0.00132	CcSEcCtD
Niacin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00132	CcSEcCtD
Niacin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00132	CcSEcCtD
Niacin—Skin exfoliation—Doxorubicin—uterine cancer	0.000539	0.00131	CcSEcCtD
Niacin—Pruritus—Progesterone—uterine cancer	0.000537	0.00131	CcSEcCtD
Niacin—Oedema—Dactinomycin—uterine cancer	0.000536	0.00131	CcSEcCtD
Niacin—Fluid retention—Doxorubicin—uterine cancer	0.000536	0.0013	CcSEcCtD
Niacin—Hypertonia—Epirubicin—uterine cancer	0.000534	0.0013	CcSEcCtD
Niacin—Vaginal infection—Doxorubicin—uterine cancer	0.000533	0.0013	CcSEcCtD
Niacin—Abnormal vision—Epirubicin—uterine cancer	0.000532	0.0013	CcSEcCtD
Niacin—Diarrhoea—Progesterone—uterine cancer	0.000519	0.00126	CcSEcCtD
Niacin—QPRT—Disease—AKR1C1—uterine cancer	0.000519	0.00672	CbGpPWpGaD
Niacin—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000518	0.00126	CcSEcCtD
Niacin—Oesophagitis—Doxorubicin—uterine cancer	0.000516	0.00126	CcSEcCtD
Niacin—Rash maculo-papular—Doxorubicin—uterine cancer	0.000513	0.00125	CcSEcCtD
Niacin—Anorexia—Dactinomycin—uterine cancer	0.000511	0.00124	CcSEcCtD
Niacin—Eye disorder—Etoposide—uterine cancer	0.00051	0.00124	CcSEcCtD
Niacin—Diabetes mellitus—Epirubicin—uterine cancer	0.000509	0.00124	CcSEcCtD
Niacin—Flushing—Etoposide—uterine cancer	0.000507	0.00123	CcSEcCtD
Niacin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00123	CcSEcCtD
Niacin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000506	0.00123	CcSEcCtD
Niacin—Dizziness—Progesterone—uterine cancer	0.000502	0.00122	CcSEcCtD
Niacin—Angiopathy—Etoposide—uterine cancer	0.000496	0.00121	CcSEcCtD
Niacin—Hypertonia—Doxorubicin—uterine cancer	0.000495	0.0012	CcSEcCtD
Niacin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.0012	CcSEcCtD
Niacin—Eczema—Epirubicin—uterine cancer	0.000493	0.0012	CcSEcCtD
Niacin—Abnormal vision—Doxorubicin—uterine cancer	0.000492	0.0012	CcSEcCtD
Niacin—Chills—Etoposide—uterine cancer	0.00049	0.00119	CcSEcCtD
Niacin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000489	0.00119	CcSEcCtD
Niacin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00118	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000485	0.00628	CbGpPWpGaD
Niacin—Alopecia—Etoposide—uterine cancer	0.000483	0.00118	CcSEcCtD
Niacin—Vomiting—Progesterone—uterine cancer	0.000482	0.00117	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—CXCL8—uterine cancer	0.000482	0.00625	CbGpPWpGaD
Niacin—Rash—Progesterone—uterine cancer	0.000478	0.00116	CcSEcCtD
Niacin—Dermatitis—Progesterone—uterine cancer	0.000478	0.00116	CcSEcCtD
Niacin—Headache—Progesterone—uterine cancer	0.000475	0.00116	CcSEcCtD
Niacin—Diabetes mellitus—Doxorubicin—uterine cancer	0.000471	0.00115	CcSEcCtD
Niacin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00115	CcSEcCtD
Niacin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000469	0.00114	CcSEcCtD
Niacin—Decreased appetite—Dactinomycin—uterine cancer	0.000466	0.00114	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—AKR1B10—uterine cancer	0.000465	0.00603	CbGpPWpGaD
Niacin—QPRT—Metabolism—POLD1—uterine cancer	0.000464	0.00602	CbGpPWpGaD
Niacin—Dermatitis bullous—Epirubicin—uterine cancer	0.000463	0.00113	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.00046	0.00596	CbGpPWpGaD
Niacin—Pain—Dactinomycin—uterine cancer	0.000459	0.00112	CcSEcCtD
Niacin—Muscle spasms—Etoposide—uterine cancer	0.000457	0.00111	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—CXCL8—uterine cancer	0.000457	0.00592	CbGpPWpGaD
Niacin—Eczema—Doxorubicin—uterine cancer	0.000456	0.00111	CcSEcCtD
Niacin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000455	0.00111	CcSEcCtD
Niacin—Nausea—Progesterone—uterine cancer	0.000451	0.0011	CcSEcCtD
Niacin—QPRT—Disease—DCN—uterine cancer	0.000449	0.00581	CbGpPWpGaD
Niacin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000443	0.00108	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AKR1B10—uterine cancer	0.000441	0.00571	CbGpPWpGaD
Niacin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000438	0.00107	CcSEcCtD
Niacin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000437	0.00106	CcSEcCtD
Niacin—Migraine—Epirubicin—uterine cancer	0.000436	0.00106	CcSEcCtD
Niacin—QPRT—Metabolism—AKR1C1—uterine cancer	0.000434	0.00563	CbGpPWpGaD
Niacin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000433	0.00106	CcSEcCtD
Niacin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000433	0.00105	CcSEcCtD
Niacin—NNMT—Metabolism—POLD1—uterine cancer	0.000432	0.00559	CbGpPWpGaD
Niacin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.00105	CcSEcCtD
Niacin—Dermatitis bullous—Doxorubicin—uterine cancer	0.000429	0.00104	CcSEcCtD
Niacin—Face oedema—Epirubicin—uterine cancer	0.000427	0.00104	CcSEcCtD
Niacin—Vertigo—Etoposide—uterine cancer	0.000427	0.00104	CcSEcCtD
Niacin—Leukopenia—Etoposide—uterine cancer	0.000426	0.00104	CcSEcCtD
Niacin—Body temperature increased—Dactinomycin—uterine cancer	0.000424	0.00103	CcSEcCtD
Niacin—Abdominal pain—Dactinomycin—uterine cancer	0.000424	0.00103	CcSEcCtD
Niacin—Loss of consciousness—Etoposide—uterine cancer	0.000418	0.00102	CcSEcCtD
Niacin—Cough—Etoposide—uterine cancer	0.000415	0.00101	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.00041	0.000997	CcSEcCtD
Niacin—Liver function test abnormal—Epirubicin—uterine cancer	0.000409	0.000995	CcSEcCtD
Niacin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000408	0.000994	CcSEcCtD
Niacin—Dry skin—Epirubicin—uterine cancer	0.000406	0.000988	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000404	0.000985	CcSEcCtD
Niacin—NNMT—Metabolism—AKR1C1—uterine cancer	0.000404	0.00523	CbGpPWpGaD
Niacin—Migraine—Doxorubicin—uterine cancer	0.000403	0.000982	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000402	0.000979	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—NRAS—uterine cancer	0.000401	0.0052	CbGpPWpGaD
Niacin—QPRT—Disease—AKR1C3—uterine cancer	0.000399	0.00517	CbGpPWpGaD
Niacin—Face oedema—Doxorubicin—uterine cancer	0.000395	0.000963	CcSEcCtD
Niacin—Hypersensitivity—Dactinomycin—uterine cancer	0.000395	0.000962	CcSEcCtD
Niacin—Muscular weakness—Epirubicin—uterine cancer	0.00039	0.000951	CcSEcCtD
Niacin—QPRT—Disease—HMGA1—uterine cancer	0.000389	0.00504	CbGpPWpGaD
Niacin—Anaphylactic shock—Etoposide—uterine cancer	0.000388	0.000945	CcSEcCtD
Niacin—QPRT—Metabolism—RRM2—uterine cancer	0.000387	0.00502	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RNF43—uterine cancer	0.000385	0.00499	CbGpPWpGaD
Niacin—Abdominal distension—Epirubicin—uterine cancer	0.000385	0.000938	CcSEcCtD
Niacin—Asthenia—Dactinomycin—uterine cancer	0.000385	0.000937	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000383	0.00497	CbGpPWpGaD
Niacin—Dysphagia—Epirubicin—uterine cancer	0.000383	0.000932	CcSEcCtD
Niacin—Influenza—Epirubicin—uterine cancer	0.000383	0.000932	CcSEcCtD
Niacin—Tachycardia—Etoposide—uterine cancer	0.000379	0.000922	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000378	0.000921	CcSEcCtD
Niacin—Skin disorder—Etoposide—uterine cancer	0.000377	0.000918	CcSEcCtD
Niacin—QPRT—Metabolism—DCN—uterine cancer	0.000376	0.00487	CbGpPWpGaD
Niacin—Dry skin—Doxorubicin—uterine cancer	0.000375	0.000914	CcSEcCtD
Niacin—Hyperhidrosis—Etoposide—uterine cancer	0.000375	0.000914	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000374	0.000911	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—uterine cancer	0.000373	0.000908	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IRF1—uterine cancer	0.000372	0.00483	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SRD5A2—uterine cancer	0.000372	0.00481	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NDUFB11—uterine cancer	0.000372	0.00481	CbGpPWpGaD
Niacin—Anorexia—Etoposide—uterine cancer	0.00037	0.000901	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—CCL2—uterine cancer	0.000369	0.00478	CbGpPWpGaD
Niacin—Bronchitis—Epirubicin—uterine cancer	0.000368	0.000896	CcSEcCtD
Niacin—Diarrhoea—Dactinomycin—uterine cancer	0.000367	0.000894	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—RNF43—uterine cancer	0.000365	0.00473	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000363	0.00471	CbGpPWpGaD
Niacin—Hypotension—Etoposide—uterine cancer	0.000363	0.000883	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—uterine cancer	0.000361	0.00088	CcSEcCtD
Niacin—NNMT—Metabolism—RRM2—uterine cancer	0.00036	0.00466	CbGpPWpGaD
Niacin—Abdominal distension—Doxorubicin—uterine cancer	0.000356	0.000868	CcSEcCtD
Niacin—QPRT—Disease—FBXW7—uterine cancer	0.000356	0.00461	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP11A1—uterine cancer	0.000354	0.00459	CbGpPWpGaD
Niacin—Dysphagia—Doxorubicin—uterine cancer	0.000354	0.000862	CcSEcCtD
Niacin—Influenza—Doxorubicin—uterine cancer	0.000354	0.000862	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—INHBA—uterine cancer	0.000353	0.00457	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCL2—uterine cancer	0.00035	0.00454	CbGpPWpGaD
Niacin—NNMT—Metabolism—DCN—uterine cancer	0.000349	0.00453	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000349	0.00452	CbGpPWpGaD
Niacin—Paraesthesia—Etoposide—uterine cancer	0.000348	0.000849	CcSEcCtD
Niacin—Dyspnoea—Etoposide—uterine cancer	0.000346	0.000843	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.000345	0.00447	CbGpPWpGaD
Niacin—Somnolence—Etoposide—uterine cancer	0.000345	0.00084	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—uterine cancer	0.000345	0.00084	CcSEcCtD
Niacin—Vomiting—Dactinomycin—uterine cancer	0.000341	0.00083	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—uterine cancer	0.00034	0.000829	CcSEcCtD
Niacin—Rash—Dactinomycin—uterine cancer	0.000338	0.000823	CcSEcCtD
Niacin—Decreased appetite—Etoposide—uterine cancer	0.000337	0.000822	CcSEcCtD
Niacin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000335	0.000816	CcSEcCtD
Niacin—QPRT—Metabolism—AKR1C3—uterine cancer	0.000334	0.00433	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—INHBA—uterine cancer	0.000334	0.00433	CbGpPWpGaD
Niacin—Jaundice—Epirubicin—uterine cancer	0.000332	0.00081	CcSEcCtD
Niacin—Stomatitis—Epirubicin—uterine cancer	0.000332	0.00081	CcSEcCtD
Niacin—Pain—Etoposide—uterine cancer	0.000332	0.000808	CcSEcCtD
Niacin—NNMT—Metabolism—CYP11A1—uterine cancer	0.000329	0.00426	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000328	0.00425	CbGpPWpGaD
Niacin—Sweating—Epirubicin—uterine cancer	0.000327	0.000796	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000324	0.0042	CbGpPWpGaD
Niacin—Nausea—Dactinomycin—uterine cancer	0.000319	0.000776	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—AKR1C1—uterine cancer	0.000317	0.00411	CbGpPWpGaD
Niacin—Gastrointestinal pain—Etoposide—uterine cancer	0.000317	0.000773	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.000317	0.00411	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKR1C3—uterine cancer	0.000311	0.00403	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00031	0.00401	CbGpPWpGaD
Niacin—Urticaria—Etoposide—uterine cancer	0.000308	0.000751	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—uterine cancer	0.000308	0.00075	CcSEcCtD
Niacin—Jaundice—Doxorubicin—uterine cancer	0.000308	0.000749	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—uterine cancer	0.000308	0.000749	CcSEcCtD
Niacin—Rhinitis—Epirubicin—uterine cancer	0.000307	0.000748	CcSEcCtD
Niacin—Body temperature increased—Etoposide—uterine cancer	0.000307	0.000747	CcSEcCtD
Niacin—Abdominal pain—Etoposide—uterine cancer	0.000307	0.000747	CcSEcCtD
Niacin—Hepatitis—Epirubicin—uterine cancer	0.000306	0.000746	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—uterine cancer	0.000306	0.000746	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—uterine cancer	0.000305	0.000742	CcSEcCtD
Niacin—Sweating—Doxorubicin—uterine cancer	0.000303	0.000737	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—uterine cancer	0.000302	0.000735	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AKR1C1—uterine cancer	0.000301	0.0039	CbGpPWpGaD
Niacin—Visual impairment—Epirubicin—uterine cancer	0.000295	0.000719	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.000294	0.0038	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CXCL8—uterine cancer	0.000292	0.00378	CbGpPWpGaD
Niacin—Eye disorder—Epirubicin—uterine cancer	0.000286	0.000697	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—uterine cancer	0.000286	0.000696	CcSEcCtD
Niacin—Tinnitus—Epirubicin—uterine cancer	0.000285	0.000695	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—uterine cancer	0.000285	0.000694	CcSEcCtD
Niacin—Flushing—Epirubicin—uterine cancer	0.000284	0.000692	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—uterine cancer	0.000284	0.000692	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—uterine cancer	0.000283	0.00069	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—uterine cancer	0.000283	0.00069	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000282	0.000687	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—uterine cancer	0.000279	0.00068	CcSEcCtD
Niacin—QPRT—Disease—CDKN2B—uterine cancer	0.000279	0.00361	CbGpPWpGaD
Niacin—Asthenia—Etoposide—uterine cancer	0.000278	0.000678	CcSEcCtD
Niacin—Angiopathy—Epirubicin—uterine cancer	0.000278	0.000677	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—CXCL8—uterine cancer	0.000277	0.00359	CbGpPWpGaD
Niacin—Chills—Epirubicin—uterine cancer	0.000275	0.000669	CcSEcCtD
Niacin—Pruritus—Etoposide—uterine cancer	0.000275	0.000669	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—uterine cancer	0.000274	0.000666	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—uterine cancer	0.000273	0.000665	CcSEcCtD
Niacin—Alopecia—Epirubicin—uterine cancer	0.000271	0.000659	CcSEcCtD
Niacin—SLC16A3—Metabolism—STAR—uterine cancer	0.000269	0.00348	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKR1B1—uterine cancer	0.000269	0.00348	CbGpPWpGaD
Niacin—Malnutrition—Epirubicin—uterine cancer	0.000267	0.000649	CcSEcCtD
Niacin—Erythema—Epirubicin—uterine cancer	0.000267	0.000649	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000266	0.00345	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000266	0.00345	CbGpPWpGaD
Niacin—Diarrhoea—Etoposide—uterine cancer	0.000266	0.000647	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—uterine cancer	0.000265	0.000645	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—uterine cancer	0.000264	0.000643	CcSEcCtD
Niacin—Flushing—Doxorubicin—uterine cancer	0.000263	0.00064	CcSEcCtD
Niacin—Flatulence—Epirubicin—uterine cancer	0.000263	0.00064	CcSEcCtD
Niacin—Tension—Epirubicin—uterine cancer	0.000262	0.000637	CcSEcCtD
Niacin—QPRT—Metabolism—STK11—uterine cancer	0.00026	0.00337	CbGpPWpGaD
Niacin—QPRT—Metabolism—CYP19A1—uterine cancer	0.00026	0.00337	CbGpPWpGaD
Niacin—Nervousness—Epirubicin—uterine cancer	0.000259	0.000631	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—uterine cancer	0.000257	0.000626	CcSEcCtD
Niacin—Dizziness—Etoposide—uterine cancer	0.000257	0.000625	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—uterine cancer	0.000256	0.000624	CcSEcCtD
Niacin—QPRT—Disease—SMAD3—uterine cancer	0.000255	0.0033	CbGpPWpGaD
Niacin—Chills—Doxorubicin—uterine cancer	0.000254	0.000619	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—uterine cancer	0.000253	0.000616	CcSEcCtD
Niacin—Vision blurred—Epirubicin—uterine cancer	0.000251	0.000612	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000251	0.00325	CbGpPWpGaD
Niacin—Alopecia—Doxorubicin—uterine cancer	0.00025	0.00061	CcSEcCtD
Niacin—Vomiting—Etoposide—uterine cancer	0.000247	0.000601	CcSEcCtD
Niacin—Erythema—Doxorubicin—uterine cancer	0.000247	0.000601	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—uterine cancer	0.000247	0.000601	CcSEcCtD
Niacin—Rash—Etoposide—uterine cancer	0.000245	0.000596	CcSEcCtD
Niacin—Dermatitis—Etoposide—uterine cancer	0.000244	0.000595	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—AKR1C3—uterine cancer	0.000244	0.00317	CbGpPWpGaD
Niacin—Headache—Etoposide—uterine cancer	0.000243	0.000592	CcSEcCtD
Niacin—Flatulence—Doxorubicin—uterine cancer	0.000243	0.000592	CcSEcCtD
Niacin—QPRT—Disease—FGFR2—uterine cancer	0.000243	0.00315	CbGpPWpGaD
Niacin—NNMT—Metabolism—CYP19A1—uterine cancer	0.000242	0.00314	CbGpPWpGaD
Niacin—NNMT—Metabolism—STK11—uterine cancer	0.000242	0.00314	CbGpPWpGaD
Niacin—Tension—Doxorubicin—uterine cancer	0.000242	0.000589	CcSEcCtD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000242	0.00313	CbGpPWpGaD
Niacin—Nervousness—Doxorubicin—uterine cancer	0.00024	0.000583	CcSEcCtD
Niacin—Vertigo—Epirubicin—uterine cancer	0.000239	0.000583	CcSEcCtD
Niacin—Syncope—Epirubicin—uterine cancer	0.000239	0.000582	CcSEcCtD
Niacin—Leukopenia—Epirubicin—uterine cancer	0.000239	0.000581	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000238	0.00309	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PGR—uterine cancer	0.000238	0.00309	CbGpPWpGaD
Niacin—Muscle spasms—Doxorubicin—uterine cancer	0.000237	0.000577	CcSEcCtD
Niacin—Palpitations—Epirubicin—uterine cancer	0.000236	0.000574	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—uterine cancer	0.000234	0.000571	CcSEcCtD
Niacin—QPRT—Disease—MTHFR—uterine cancer	0.000234	0.00303	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000233	0.00302	CbGpPWpGaD
Niacin—Cough—Epirubicin—uterine cancer	0.000233	0.000566	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—uterine cancer	0.000232	0.000566	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AKR1C3—uterine cancer	0.000232	0.003	CbGpPWpGaD
Niacin—Nausea—Etoposide—uterine cancer	0.000231	0.000561	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—YWHAE—uterine cancer	0.000227	0.00294	CbGpPWpGaD
Niacin—Arthralgia—Epirubicin—uterine cancer	0.000227	0.000553	CcSEcCtD
Niacin—Myalgia—Epirubicin—uterine cancer	0.000227	0.000553	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PGR—uterine cancer	0.000226	0.00292	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000225	0.000549	CcSEcCtD
Niacin—Dry mouth—Epirubicin—uterine cancer	0.000222	0.000541	CcSEcCtD
Niacin—Vertigo—Doxorubicin—uterine cancer	0.000222	0.00054	CcSEcCtD
Niacin—Syncope—Doxorubicin—uterine cancer	0.000221	0.000539	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—uterine cancer	0.000221	0.000538	CcSEcCtD
Niacin—Palpitations—Doxorubicin—uterine cancer	0.000218	0.000531	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—FBXW7—uterine cancer	0.000218	0.00282	CbGpPWpGaD
Niacin—Oedema—Epirubicin—uterine cancer	0.000218	0.00053	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—uterine cancer	0.000218	0.00053	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—uterine cancer	0.000217	0.000528	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—uterine cancer	0.000217	0.00281	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—YWHAE—uterine cancer	0.000215	0.00279	CbGpPWpGaD
Niacin—Cough—Doxorubicin—uterine cancer	0.000215	0.000524	CcSEcCtD
Niacin—Shock—Epirubicin—uterine cancer	0.000214	0.000521	CcSEcCtD
Niacin—Tachycardia—Epirubicin—uterine cancer	0.000212	0.000517	CcSEcCtD
Niacin—Skin disorder—Epirubicin—uterine cancer	0.000211	0.000515	CcSEcCtD
Niacin—SLC16A3—Metabolism—POLD1—uterine cancer	0.000211	0.00273	CbGpPWpGaD
Niacin—Hyperhidrosis—Epirubicin—uterine cancer	0.00021	0.000512	CcSEcCtD
Niacin—Myalgia—Doxorubicin—uterine cancer	0.00021	0.000511	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—uterine cancer	0.00021	0.000511	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000209	0.000508	CcSEcCtD
Niacin—Anorexia—Epirubicin—uterine cancer	0.000207	0.000505	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—FBXW7—uterine cancer	0.000206	0.00268	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—uterine cancer	0.000205	0.0005	CcSEcCtD
Niacin—Hypotension—Epirubicin—uterine cancer	0.000203	0.000495	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000201	0.00049	CcSEcCtD
Niacin—Oedema—Doxorubicin—uterine cancer	0.000201	0.00049	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IRF1—uterine cancer	0.000201	0.00261	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NDUFB11—uterine cancer	0.000201	0.0026	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SRD5A2—uterine cancer	0.000201	0.0026	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000198	0.000483	CcSEcCtD
Niacin—Shock—Doxorubicin—uterine cancer	0.000198	0.000482	CcSEcCtD
Niacin—SLC16A3—Metabolism—AKR1C1—uterine cancer	0.000197	0.00255	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—uterine cancer	0.000197	0.000479	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—uterine cancer	0.000196	0.000478	CcSEcCtD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000196	0.00254	CbGpPWpGaD
Niacin—QPRT—Metabolism—MTHFR—uterine cancer	0.000196	0.00254	CbGpPWpGaD
Niacin—Skin disorder—Doxorubicin—uterine cancer	0.000196	0.000476	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—uterine cancer	0.000195	0.000476	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000195	0.000474	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—uterine cancer	0.000194	0.000472	CcSEcCtD
Niacin—Somnolence—Epirubicin—uterine cancer	0.000193	0.000471	CcSEcCtD
Niacin—Anorexia—Doxorubicin—uterine cancer	0.000192	0.000467	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—uterine cancer	0.000191	0.000466	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—STK11—uterine cancer	0.00019	0.00247	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CCL2—uterine cancer	0.000189	0.00246	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—uterine cancer	0.000189	0.000461	CcSEcCtD
Niacin—Hypotension—Doxorubicin—uterine cancer	0.000188	0.000458	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000188	0.000457	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.000186	0.00242	CbGpPWpGaD
Niacin—Pain—Epirubicin—uterine cancer	0.000186	0.000453	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000183	0.000447	CcSEcCtD
Niacin—Insomnia—Doxorubicin—uterine cancer	0.000182	0.000443	CcSEcCtD
Niacin—NNMT—Metabolism—MTHFR—uterine cancer	0.000182	0.00236	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—uterine cancer	0.000181	0.00044	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—STK11—uterine cancer	0.00018	0.00234	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCL2—uterine cancer	0.00018	0.00233	CbGpPWpGaD
Niacin—Dyspnoea—Doxorubicin—uterine cancer	0.000179	0.000437	CcSEcCtD
Niacin—Somnolence—Doxorubicin—uterine cancer	0.000179	0.000436	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SOCS3—uterine cancer	0.000178	0.00231	CbGpPWpGaD
Niacin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000178	0.000433	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—uterine cancer	0.000177	0.000432	CcSEcCtD
Niacin—SLC16A3—Metabolism—RRM2—uterine cancer	0.000176	0.00228	CbGpPWpGaD
Niacin—Decreased appetite—Doxorubicin—uterine cancer	0.000175	0.000426	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000174	0.000423	CcSEcCtD
Niacin—Urticaria—Epirubicin—uterine cancer	0.000173	0.000421	CcSEcCtD
Niacin—Pain—Doxorubicin—uterine cancer	0.000172	0.000419	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—uterine cancer	0.000172	0.000419	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—uterine cancer	0.000172	0.000419	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.000171	0.00222	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000171	0.00222	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN2B—uterine cancer	0.000171	0.00221	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—DCN—uterine cancer	0.000171	0.00221	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SOCS3—uterine cancer	0.000169	0.00219	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1R—uterine cancer	0.000166	0.00215	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—uterine cancer	0.000165	0.00214	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000165	0.000401	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CDKN2B—uterine cancer	0.000162	0.0021	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP11A1—uterine cancer	0.000161	0.00208	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—uterine cancer	0.00016	0.00039	CcSEcCtD
Niacin—Urticaria—Doxorubicin—uterine cancer	0.00016	0.000389	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—uterine cancer	0.000159	0.000388	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—uterine cancer	0.000159	0.000388	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.000158	0.00205	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1R—uterine cancer	0.000157	0.00204	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—uterine cancer	0.000156	0.00203	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—uterine cancer	0.000156	0.00038	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SMAD3—uterine cancer	0.000156	0.00202	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—uterine cancer	0.000154	0.000375	CcSEcCtD
Niacin—QPRT—Disease—ERBB2—uterine cancer	0.000152	0.00198	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKR1C3—uterine cancer	0.000152	0.00197	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.00015	0.00195	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL8—uterine cancer	0.00015	0.00194	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—uterine cancer	0.000149	0.000362	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—FGFR2—uterine cancer	0.000149	0.00193	CbGpPWpGaD
Niacin—Hypersensitivity—Doxorubicin—uterine cancer	0.000148	0.000361	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SMAD3—uterine cancer	0.000148	0.00191	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STAR—uterine cancer	0.000145	0.00188	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1B1—uterine cancer	0.000145	0.00188	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—uterine cancer	0.000144	0.000352	CcSEcCtD
Niacin—Dizziness—Epirubicin—uterine cancer	0.000144	0.00035	CcSEcCtD
Niacin—Pruritus—Doxorubicin—uterine cancer	0.000142	0.000347	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CXCL8—uterine cancer	0.000142	0.00184	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000141	0.00183	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1B—uterine cancer	0.000141	0.00183	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGFR2—uterine cancer	0.000141	0.00183	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000139	0.00181	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—uterine cancer	0.000138	0.000337	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—uterine cancer	0.000138	0.000335	CcSEcCtD
Niacin—Rash—Epirubicin—uterine cancer	0.000137	0.000334	CcSEcCtD
Niacin—Dermatitis—Epirubicin—uterine cancer	0.000137	0.000334	CcSEcCtD
Niacin—Headache—Epirubicin—uterine cancer	0.000136	0.000332	CcSEcCtD
Niacin—QPRT—Disease—CTNNB1—uterine cancer	0.000133	0.00173	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—uterine cancer	0.000133	0.000324	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000132	0.00171	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—uterine cancer	0.00013	0.00168	CbGpPWpGaD
Niacin—Nausea—Epirubicin—uterine cancer	0.000129	0.000315	CcSEcCtD
Niacin—Vomiting—Doxorubicin—uterine cancer	0.000128	0.000312	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ESR1—uterine cancer	0.000127	0.00165	CbGpPWpGaD
Niacin—Rash—Doxorubicin—uterine cancer	0.000127	0.000309	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—uterine cancer	0.000127	0.000309	CcSEcCtD
Niacin—Headache—Doxorubicin—uterine cancer	0.000126	0.000307	CcSEcCtD
Niacin—QPRT—Disease—EP300—uterine cancer	0.000124	0.00161	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ESR1—uterine cancer	0.000121	0.00156	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—uterine cancer	0.00012	0.00156	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—uterine cancer	0.00012	0.000291	CcSEcCtD
Niacin—SLC16A3—Metabolism—STK11—uterine cancer	0.000118	0.00153	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP19A1—uterine cancer	0.000118	0.00153	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—EP300—uterine cancer	0.000116	0.00151	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—uterine cancer	0.000116	0.0015	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—uterine cancer	0.000114	0.00148	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—POLD1—uterine cancer	0.000114	0.00147	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL2—uterine cancer	0.000112	0.00145	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—uterine cancer	0.00011	0.00143	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—uterine cancer	0.000109	0.00141	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—uterine cancer	0.000109	0.00141	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C1—uterine cancer	0.000106	0.00138	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL2—uterine cancer	0.000106	0.00137	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—uterine cancer	0.000105	0.00136	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	0.000104	0.00135	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—uterine cancer	0.000104	0.00135	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—uterine cancer	0.000103	0.00134	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000103	0.00133	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—uterine cancer	0.000101	0.00131	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—uterine cancer	9.98e-05	0.00129	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—uterine cancer	9.92e-05	0.00129	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—uterine cancer	9.81e-05	0.00127	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—uterine cancer	9.65e-05	0.00125	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—uterine cancer	9.5e-05	0.00123	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RRM2—uterine cancer	9.49e-05	0.00123	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—uterine cancer	9.36e-05	0.00121	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—uterine cancer	9.33e-05	0.00121	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—DCN—uterine cancer	9.21e-05	0.00119	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—uterine cancer	9.17e-05	0.00119	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—uterine cancer	9.01e-05	0.00117	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—uterine cancer	8.89e-05	0.00115	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—uterine cancer	8.85e-05	0.00115	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—uterine cancer	8.85e-05	0.00115	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—uterine cancer	8.79e-05	0.00114	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP11A1—uterine cancer	8.68e-05	0.00112	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—uterine cancer	8.64e-05	0.00112	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—uterine cancer	8.6e-05	0.00111	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—uterine cancer	8.55e-05	0.00111	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—uterine cancer	8.49e-05	0.0011	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—uterine cancer	8.39e-05	0.00109	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—uterine cancer	8.34e-05	0.00108	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—uterine cancer	8.32e-05	0.00108	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C3—uterine cancer	8.2e-05	0.00106	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—uterine cancer	8.19e-05	0.00106	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—uterine cancer	8.17e-05	0.00106	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—uterine cancer	8.1e-05	0.00105	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—uterine cancer	7.96e-05	0.00103	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—uterine cancer	7.96e-05	0.00103	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—uterine cancer	7.76e-05	0.00101	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—uterine cancer	7.74e-05	0.001	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—uterine cancer	7.68e-05	0.000995	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—uterine cancer	7.59e-05	0.000983	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—uterine cancer	7.54e-05	0.000977	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—uterine cancer	7.49e-05	0.000971	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—uterine cancer	7.36e-05	0.000954	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—uterine cancer	7.19e-05	0.000932	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—uterine cancer	7.19e-05	0.000931	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—uterine cancer	7.14e-05	0.000925	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—uterine cancer	7.1e-05	0.00092	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—uterine cancer	7.03e-05	0.00091	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—uterine cancer	6.81e-05	0.000883	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—uterine cancer	6.73e-05	0.000872	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP19A1—uterine cancer	6.39e-05	0.000827	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STK11—uterine cancer	6.39e-05	0.000827	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—uterine cancer	6.28e-05	0.000814	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—uterine cancer	6.28e-05	0.000813	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—uterine cancer	6.11e-05	0.000792	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—uterine cancer	5.95e-05	0.000771	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—uterine cancer	5.87e-05	0.000761	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—uterine cancer	5.83e-05	0.000756	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—uterine cancer	5.79e-05	0.000751	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—uterine cancer	5.61e-05	0.000727	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NDUFB11—uterine cancer	5.59e-05	0.000724	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRD5A2—uterine cancer	5.59e-05	0.000724	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—uterine cancer	5.43e-05	0.000704	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—uterine cancer	5.32e-05	0.00069	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—uterine cancer	5.19e-05	0.000673	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—uterine cancer	5.15e-05	0.000667	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—uterine cancer	5.06e-05	0.000655	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—uterine cancer	4.94e-05	0.000641	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—uterine cancer	4.92e-05	0.000638	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—uterine cancer	4.8e-05	0.000622	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—uterine cancer	4.71e-05	0.000611	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—uterine cancer	4.64e-05	0.000602	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—uterine cancer	4.59e-05	0.000594	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—uterine cancer	4.49e-05	0.000582	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—uterine cancer	4.35e-05	0.000563	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—uterine cancer	4.3e-05	0.000557	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1B1—uterine cancer	4.04e-05	0.000524	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STAR—uterine cancer	4.04e-05	0.000524	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—uterine cancer	3.79e-05	0.000492	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—uterine cancer	3.49e-05	0.000452	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—POLD1—uterine cancer	3.17e-05	0.000411	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.97e-05	0.000384	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—uterine cancer	2.85e-05	0.000369	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—uterine cancer	2.67e-05	0.000346	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RRM2—uterine cancer	2.64e-05	0.000343	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DCN—uterine cancer	2.57e-05	0.000333	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—uterine cancer	2.55e-05	0.00033	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.42e-05	0.000313	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.28e-05	0.000296	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—uterine cancer	1.88e-05	0.000244	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.78e-05	0.00023	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STK11—uterine cancer	1.78e-05	0.00023	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—uterine cancer	1.54e-05	0.000199	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—uterine cancer	1.34e-05	0.000173	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—uterine cancer	7.44e-06	9.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—uterine cancer	7.09e-06	9.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—uterine cancer	5.25e-06	6.8e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—uterine cancer	4.29e-06	5.55e-05	CbGpPWpGaD
